CareDx Inc.

Last updated September 27, 2026

Organization details

Legal name
CareDx Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
CDNA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001217234

Board of directors

Chief executives

John Walter Hanna Jr. · President & CEO
Since April 2024

Board connections

5 of this board's directors also sit on 8 other boards.

Network of CareDx Inc.'s board connections Kyverna Therapeutics Inc. Kyverna Therapeutics I... BridgeBio Pharma Inc. BridgeBio Pharma Inc. Intellia Therapeutics Inc. Intellia Therapeutics... Pacific Biosciences of California Inc. Pacific Biosciences of... Progyny Inc. Progyny Inc. Spok Holdings Inc. Spok Holdings Inc. UroGen Pharma Ltd. UroGen Pharma Ltd. Voyager Therapeutics Inc. Voyager Therapeutics I... Christine Cournoyer Christine Cournoyer Fred E. Cohen Fred E. Cohen Grace Colon Grace Colon Hannah Valantine Hannah Valantine Peter Maag Peter Maag CareDx Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 17, 2024 Johnson Alexander L Officer (See Remarks) Shares withheld for tax −9,253 $13.54 $125,286
Jun 14, 2024 William A. Hagstrom Director Grant or award +10,570 — —
Jun 14, 2024 Arthur A. Torres Director Grant or award +10,570 — —
Jun 14, 2024 Peter Maag Director Grant or award +10,570 — —
Jun 14, 2024 Hannah Valantine Director Grant or award +10,570 — —
Jun 14, 2024 Michael Goldberg Director Grant or award +10,570 — —
Jun 14, 2024 Fred E. Cohen Director Grant or award +10,570 — —
Jun 14, 2024 George Bickerstaff Director Grant or award +10,570 — —
Jun 14, 2024 Richard Bryan Riggsbee Director Grant or award +10,570 — —
Jun 13, 2024 Richard Bryan Riggsbee Director Grant or award +6,844 — —
Jun 6, 2024 Novack Jeffrey Adam Officer (Secretary and General Counsel) Shares withheld for tax −1,713 $15.42 $26,414
May 28, 2024 Jain Abhishek Officer (Chief Financial Officer) Shares withheld for tax −1,901 $16.15 $30,701
May 14, 2024 George Bickerstaff Director Option exercise +5,255 $10.00 $52,550
May 1, 2024 Novack Jeffrey Adam Officer (Secretary and General Counsel) Shares withheld for tax −1,905 $9.18 $17,488
May 1, 2024 Jain Abhishek Officer (Chief Financial Officer) Shares withheld for tax −7,371 $9.18 $67,666

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.